With its total market value of the company’s outstanding shares, the market cap of Zimmer Biomet Holdings, Inc. (NYSE:ZBH) in today’s trade was 23503.54. Zimmer Biomet Holdings, Inc. traded at a P/E ratio of 77.83, suggesting the potentiality of a higher growth in the future. By maintaining an average market P/E ratio of 20-25 times the earnings, the company asserts that they are certainly not losing money. It also provides an insight on whether the company is undervalued or overvalued.
The valuation method to compare Zimmer Biomet Holdings, Inc.’s current share price to its expected per-share earnings via Forward P/E ratio shows a value of 12.54, thus, allowing investors to take a quick look on the company’s finances irrespective of its complex details from an accounting report. The corporation devours on a price-to-book ratio of 2.44, revealing its asset value weighed up against the market price of its stock.
At present, Zimmer Biomet Holdings, Inc. has a dividend yield of 0.82% * with a payout ratio of 62.80% *. The current rate undoubtedly measures the productivity of the firm’s investment alongside the indications on the stability of the company’s share price. All together, the existing dividend gives investors a measure to how much cash flow they are getting for each dollar invested in an equity position. The payout ratio also demonstrates whether the company is using much of its incomes to reinvest in the company in order to progress further.
Zimmer Biomet Holdings, Inc. has an EPS of * 1.51, revealing the EPS growth this year at * 95.10%. As a result, the EPS growth for the following year exhibits * 9.55% with an EPS growth for the past 5 years at * -17.80%.
Return on assets for Zimmer Biomet Holdings, Inc. is valued at 1.20%, outlining the total sum of profit the company cultivates as a percentage of the value of its total assets. It has a ROI of 3.50%, scheming the gains and losses generated on its investments relative to the quantity of money invested. The amount will help investors make financial decisions, to compare Zimmer Biomet Holdings, Inc. profitability or the efficiency on various investments. The current ratio is valued at 2 with a quick ratio of 1.1.
The company retains a gross margin of 69.00% and an operating profit of 10.70%, leading to the profit margin of 4.00%. Its weekly performance was measured at -1.09%, ensuing a performance for the month at 0.31%.
In its bullish and bearish sentiment, the company illustrates the volatility for the week at 0.92% * with the volatility for the month at 1.05% *. The 52-Week High of -10.83% serves as an indicator for potential stakeholders with a 52-Week Low of 24.21%.
Acting as the core component for the financial analysis and forecasting price variations, the company clutches a market price of 118.51 with a change in price of 0.77%.
Disclaimer: Outlined statistics and information communicated in the above editorial are merely a work of the authors. They do not ponder or echo the certified policy or position of any business stakeholders, financial specialists, or economic analysts. Specimens laid down on the editorial above are only cases with information collected from various sources. The authority will not be liable for anyone who makes stock portfolio or financial decisions as per the editorial, which is based only on limited and open source information. Conclusions from the analysis of the editorial shall not depict the position of any analysts or financial professionals.
*TBA = To be announced